Grupo de investigación en biomarcadores metabólicos
METABOMARK
Karolinska Institute
Estocolmo, SueciaPublicacións en colaboración con investigadores/as de Karolinska Institute (2)
2019
-
Two-Week Aflibercept or Erlotinib Administration Does Not Induce Changes in Intestinal Morphology in Male Sprague–Dawley Rats But Aflibercept Affects Serum and Urine Metabolic Profiles
Translational Oncology, Vol. 12, Núm. 8, pp. 1122-1130
2017
-
Chemotherapy-induced gastrointestinal toxicity is associated with changes in serum and urine metabolome and fecal microbiota in male Sprague–Dawley rats
Cancer Chemotherapy and Pharmacology, Vol. 80, Núm. 2, pp. 317-332